Results 201 to 210 of about 18,536,823 (334)
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song+11 more
wiley +1 more source
Cell line authentication using optical genome mapping. [PDF]
Chialastri A+4 more
europepmc +1 more source
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton+17 more
wiley +1 more source
GROWTH OF MEASLES VIRUS IN A MOUSE DERIVED ESTABLISHED CELL LINE L CELLS
S. Kohno+2 more
openalex +2 more sources
Human T lymphocyte cell line producing colony-stimulating activity [PDF]
DW Golde, S QUAN, MJ Cline
openalex +1 more source
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop+10 more
wiley +1 more source
Assessment of Vault Particles in Cancer Cell Line-Derived Extracellular Vesicle Preparations. [PDF]
Liu X+6 more
europepmc +1 more source
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed+8 more
wiley +1 more source
Development and Characterization of the NISTCHO Reference Cell Line. [PDF]
Dahodwala H+19 more
europepmc +1 more source